Patents Assigned to Merck & Co., Inc. and Merck Sharp & Dohme Corp.
  • Tyrosine kinase inhibitors
    Patent number: 7790739
    Abstract: The present invention relates to imidazo[1,2-a]pyrimidine derivatives, that are useful for treating cellular proliferative diseases, for treating disorders associated with MET activity, and for inhibiting the receptor tyrosine kinase MET. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
    Type: Grant
    Filed: October 18, 2006
    Date of Patent: September 7, 2010
    Assignee: Merck & Co., Inc. and Merck Sharp & Dohme Corp.
    Inventors: Jongwon Lim, Ana Esther Gabarda Ortega